Prognostic Factors for treatment and follow-up of patients after colorectal surgery

Completed

• Conditions: chemo- en radiotherapeutische voorbehandelingseffecten op maagdarm neoplasmata; colorectal cancer; gut cancer; 10017991; 10017998

• Registration Number: NL-OMON31685
• Lead Sponsor: Atrium Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 18 June 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 400

Inclusion Criteria

patient before pre-treatment of or who recently underwent (pre-treatment for) colorectal surgery for colorectal neoplasmata

Exclusion Criteria

no exclusion criteria

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Parameters which will be evaluated are the following:<br /><br><br /><br><br /><br>- CRP (C-Reactive Protein)<br /><br>- Leucocytes<br /><br>- CEA (Carcino Embrionic Antigen)<br /><br>- flowcytometric measurement of CEA in activated macrophages<br /><br>- flowcytometric measurement of M30 in activated macrophages<br /><br>- flowcytometric measurement of Cytokeratine 18 in activated macrophages<br /><br><br /><br>- tumor regression by chemoradiation-therapy</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>not available</p><br>